L-canavanine is a common non-protein amino acid found naturally in alfalfa sprouts, broad beans, jack beans, and a number of other legume foods and animal feed ingredients 1 at up to 2.4% of food dry matter. This analog of arginine (Figure 1.) can also block NO synthesis 2345, interfere with normal ammonia disposal 67, charge tRNAarg, cause the synthesis of canavanyl proteins 8, as well as prevent normal reproduction in arthropods 9 and rodents 10.

Canavanine has also been reported to induce a condition that mimics systemic lupus erythematosus (SLE) in primates 1112, to increase antibodies to nuclear components and promote SLE-like lesions in auto immune-susceptible (e.g., (NZB X NZW)F1) mice 13.

In our previous study 14, eighteen female BALB/c mice were fed a 23.4% protein diet containing 1.56% L-canavanine sulfate (equivalent to 1% L-canavanine base) and eighteen control mice received control diet (23.4% protein) from 84–477 days of age. More canavanine-fed mice (16 of 18) survived to age 477 days than those fed the basal diet (9 of 18) (X ² with Yates correction = 24.8).

The death rate and median life span of control mice were consistent with previously reported survival studies of female BALB-C mice fed high protein diets 15. Necropsy and histopathology from both experimental animals and co-housed cages of contemporary sentinel mice performed by the University of California Comparative Pathology Laboratory (Davis, Ca.) did not detect any significant gross or histopathological lesions, parasites or pathogenic bacteria, viruses or mycoplasma. Serology results were negative as well. There was no evidence of infectious disease and no evidence of the lung tumors often found in older BALB-C mice 15. One sentinel, but no experimental animals, showed evidence of a lymphosarcoma.

Kristal and Yu 16 have suggested that aging "...results in deleterious changes in cellular, intercellular, tissue and organismic functions."

Apparently, canavanine postponed the type of physiological decline that results in earlier death due to the inability of these aging mice to maintain homeostasis in the face of undetectable disease or some other stress.

These were serendipitous findings during a project designed to explore the mechanism of diet-induced autoimmunity. Ironically, no positive ANAs or anti SSDNA or anti dsDNA titers were detected in these mice as a result of canavanine treatment.

Previous reports of life span extension by restricting the intake of energy 17, protein 18, tryptophan 19 and methionine 20 have been accompanied by severe reductions in growth and eventual body size relative to controls. The severe stunting usually associated with amino acid deficiency and extended life span was not observed in the BALBc mice 14.

Our earlier results did leave unanswered the question of whether canavanine was extending life or merely offsetting the life-shortening effects of a very high protein diet. Since the objectives of the original investigation were unrelated to lifespan determination and required the harvest of body tissues, full lifespan data were not available.

The purpose of the experiment reported here was to test the hypothesis that canavanine will reduce middle age mortality and extend the lifespan of female BALB/c mice consuming a diet containing moderate concentrations of protein (15.7% DMB).

Five female 100-day-old 20-gram BALB/cAnHsd mice (first generation offspring of mice obtained from Harlan Sprague-Dawley) were assigned to each of twelve cages and six cages were randomly assigned to each of two treatments: Control = 25 g of ground Agway 1000 lab animal feed or Canavanine = 25 g of a mixture containing 1.56% canavanine sulfate (prepared by the method of Rosenthal 21) and 98.44% ground Agway 1000 lab animal feed resulting in a diet containing 1% L-canavanine base (Table 1). All animals were weighed monthly for the first 28 months of age and cause of death determined by symptoms and necropsy. As animals died, feed offerings were reduced, but 5 grams per head ratio was maintained.

At 833 days of age, blood samples were taken from the supraorbital sinus of the 37 surviving mice (19 controls and 18 canavanine-fed) and analyzed for antinuclear antibodies (ANA) by the methods of Naiki, et al 22.

Variations in lifespan and ANA values were evaluated by analyses of variance and median values were contrasted by the Mann Whitney procedure 23.

Neither mean (870.0 vs 873.2, SEM = 34.2) nor median (885 vs 902, W = 923.5) lifespan differed significantly between mice fed canavanine and those fed the same basal diet without canavanine, respectively. (Figure 2).

Although mean (20.39 vs 19.84) indices of ANA titers at 833 days of age were also similar for canavanine and control treatments, one canavanine-fed mouse displayed an unusually high titer (10X SEM above mean). (Figure 3).

About half of the mice (48.3%) displayed mammary tumors, pulmonary adenocarcinomas or both at the time of death (17 canavanine mice and 12 controls; but the difference was not significant by Chi-square analysis, 23) (Table 2). No infectious diseases were detected in either experimental or sentinel mice.

The median longevity of control mice observed in this experiment (in which a 15.7% protein was fed) considerably exceeds that of the previous trial in which the basal diet contained 23.4% protein (902 d vs 449 d). Storer 24 fed BALB/c mice a diet of protein content between those two extremes (17%, but probably closer to 19% on a dry matter basis) and observed mean longevity for females of 575 d, a result falling between our two observations. That decreasing protein concentrations should extend rodent lifespan is not a unique finding, the phenomenon is well known. The apparent corrective effect of canavanine at high protein concentrations and lack of effect at more moderate concentrations does offer a new dimension to dietary modulation of longevity that bears further study.

A number of populations consume protein in amounts that far exceed known nutritional requirements (humans in some Western countries, alfalfa-fed horses in some Western States and pet dogs in most of the Northern Hemisphere). The impact of these protein intakes on human and domestic animal longevity and the possible corrective effects of non-protein amino acids on those effects should interest a variety of medical, veterinary and nutritional workers.

For the second time, we have failed to induce significant autoimmune disease signs with dietary canavanine in BALB/c mice. Since this can be done in autoimmune susceptible strains and hybrids and in the "normal" (DBA/2) strain of mice 13, genetic differences may play a role in an animal's response to this secondary plant compound.

These preliminary experiments were not contemporary comparisons, nor were they conducted with both sexes, with the same source of BALB/c mice, the same basal diets or at the same locations. Known autoimmune-susceptible lines were not challenged in those trials. Although the data from those trials did indicate a canavanine-protein concentration interaction, we propose a contemporary, comprehensive, integrated experiment including both autoimmune susceptible and more normal populations. The proposed work will be more conclusive and provide an opportunity to examine the generality of the canavanine longevity effect, suggest mechanisms for its occurrence and find out if positive effects on oxidation event-dependent aging might be offset by autoimmunity in susceptible individuals. Examination of such indices as tissue and urine nitrate/nitrite, 8-OH deoxyguanidine, canavanyl residues in specific and total proteins would all contribute to a better understanding of mechanisms of longevity modulation.

This and a previous study suggest that an interaction between dietary protein concentration and canavanine effects on longevity may exist in BALB/c mice. Contemporary trials that vary both protein and canavanine concentrations are needed to test this possibility more conclusively.

The author(s) declare that they have no competing interests.